Volume 13, Issue 4 (July 2011) 13, 624–625; 10.1038/aja.2011.74
What is appropriate neoadjuvant/adjuvant androgen deprivation for high-risk/locally advanced prostate cancer?
Mikio Namiki and Hiroyuki Konaka
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Ishikawa 920-8640, Japan
Correspondence: Dr M Namiki, (namiki1@kenroku.kanazawa-u.ac.jp)
Abstract |
No abstract available
PDF |
PDF |
|
|
Browse: 3067 |
|